首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Anti-Inflammatory Effect of Feiyangchangweiyan Capsule on Rat Pelvic Inflammatory Disease through JNK/NF-kappa B Pathway
【24h】

Anti-Inflammatory Effect of Feiyangchangweiyan Capsule on Rat Pelvic Inflammatory Disease through JNK/NF-kappa B Pathway

机译:通过JNK / NF-Kappa途径对Feiyangchangweiyyan胶囊胶囊对大鼠盆腔炎疾病的抗炎作用

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives. In this study, we aimed to illustrate the preventive effect and possible mechanisms of Feiyangchangweiyan capsule (FYCWYC) on rat pelvic inflammatory disease (PID) model. Methods. To construct the rat PID model, upper genital tract was infected bymultipathogen, and then drugs were orally administered for 8 days. The histological examination, immunohistochemical analysis, and ELISA were carried out. Furthermore, Western blotting was used to analyze the expression of Akt, MAPKs, NF-kappa B p65, and I kappa B-alpha in uterus. Results. As the results showed, infiltrations of neutrophils and lymphocytes in uterus were significantly suppressed, and IL-1 beta, IL-6, CXCL-1, and TNF-alpha. were also reduced in a dose-dependent manner. We also found that FYCWYC inhibited apoptosis induced by infection. Furthermore, FYCWYC could block the infection-induced nuclear translocation of NF-kappa B. We found that FYCWYC treatment only decreased the phosphorylation of JNK induced by infection and had no effects on Akt and P38. Additional, the effects of SP600125, an inhibitor of phospho-JNK, were similar to the results of FYCWYC. Conclusions. Taken together, our results demonstrated that FYCWYC had anti-inflammatory effect in pathogen-induced PID model, and the mechanism might be through inhibiting NF-kappa B nuclear translocation which is mediated by JNK.
机译:目标。在这项研究中,我们旨在说明Feiyangchangweiiyan胶囊(FYCWYC)对大鼠盆腔炎(PID)模型的预防效果和可能的机制。方法。为了构建大鼠PID模型,上生生殖道被MultiPathogen感染,然后口服药物施用8天。进行组织学检查,免疫组织化学分析和ELISA。此外,Western印迹用于分析子宫内AKT,MAPK,NF-KAPPA B P65和I Kappa B-α的表达。结果。结果表明,子宫中嗜中性粒细胞和淋巴细胞的浸润显着抑制,IL-1β,IL-6,CXCL-1和TNF-α。以剂量依赖性方式也降低。我们还发现FYCWYC抑制了感染诱导的细胞凋亡。此外,FYCWYC可以阻断感染诱导的NF-Kappa B的核转移。我们发现FYCWYC治疗仅降低了通过感染诱导的JNK的磷酸化,对AKT和P38没有影响。另外,SP600125是磷酸-JNK抑制剂的影响类似于FYCWYC的结果。结论。我们的结果表明,FYCWYC在病原菌诱导的PID模型中具有抗炎作用,并且该机制可能是通过抑制由JNK介导的NF-Kappa B核易位。

著录项

  • 来源
  • 作者单位

    Shaanxi Univ Chinese Med Sch Pharm Xianyang 712000 Peoples R China;

    Northwest Agr &

    Forestry Univ Coll Chem &

    Pharm Yangling 712100 Peoples R China;

    Fourth Mil Med Univ Sch Pharm Dept Nat Med Xian 710032 Shaanxi Peoples R China;

    Shaanxi Junbisha Pharmaceut Ltd Co Xianyang Shaanxi Peoples R China;

    Fourth Mil Med Univ Sch Pharm Dept Nat Med Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Sch Pharm Dept Nat Med Xian 710032 Shaanxi Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号